University College London Hospitals
213
29
41
86
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.2%
9 terminated/withdrawn out of 213 trials
90.5%
+4.0% vs industry average
8%
18 trials in Phase 3/4
8%
7 of 86 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (213)
AI in Endoscopic Transsphenoidal Surgery
Role: collaborator
Oral N-acetylcysteine for Retinitis Pigmentosa
Role: collaborator
Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma
Role: collaborator
Middle Meningeal Artery Coagulation During Burr-Hole Drainage for Chronic Subdural Haematoma (BURR-MMA)
Role: collaborator
NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
Role: collaborator
Intensive Comprehensive Aphasia Programme for People With Post-Stroke Aphasia
Role: collaborator
The STOP-MED CTRCD Trial
Role: collaborator
Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)
Role: collaborator
Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)
Role: collaborator
Physical Activity Intervention for MPS
Role: collaborator
A Study on Remote Health Support for Patients With Heart Failure.
Role: collaborator
Plant-Protein Dominant Tube Feed Study
Role: collaborator
Multi-omics Study in Citrin Deficiency
Role: collaborator
A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
Role: collaborator
NeoSCB App for Screening Jaundice in Newborns
Role: collaborator
TIPS Microspheres for Perianal Fistula
Role: collaborator
Evaluation of PKU Sphere in Maternal PKU
Role: collaborator
Air Pollution and Pregnancy
Role: collaborator
Understanding Cauda Equina Syndrome
Role: collaborator
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Role: collaborator